Shandong Boan Biotechnology Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
Profit Before Tax
79.00
-131.00
-385.00
-271.00
-270.00
Adjustment
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-353.00
-14.00
16.00
-87.00
-328.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-163.00
-29.00
-266.00
-267.00
-582.00
Cash Flow from Investing Activities
-393.00
-325.00
-123.00
-531.00
-21.00
Cash Flow from Financing Activities
548.00
328.00
15.00
1,474.00
605.00
Net Cash Inflow / Outflow
-8.00
-29.00
-369.00
668.00
1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
-2.00
5.00
-6.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shandong Boan Biotechnology Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
79.3532588090538
-485.009055099572
564.00
116.36%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-353.523110310824
-20.0439854273168
-333.00
-1663.74%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-163.897781376019
-251.323325362712
88.00
34.79%
Cash Flow from Investing Activities
-393.457242877946
1059.69169932939
-1,452.00
-137.13%
Cash Flow from Financing Activities
548.411261777146
-309.648333238558
857.00
277.11%
Net Cash Inflow / Outflow
-8.92858334302365
517.069247753296
-525.00
-101.73%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.0151791337950615
18.3492070251739
-18.00
-99.92%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -462.71% vs 89.05% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-163.90
-29.13
-462.71%






